Last updated on June 2019

An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease


Brief description of study

This study seeks to evaluate the safety and efficacy of brazikumab versus placebo (Stage I) and versus an active comparator (Stage 2) in participants with moderately to severely active CD and will include assessments of clinical response as demonstrated by improvement of symptoms and colonic mucosal appearance as observed on endoscopy

Clinical Study Identifier: NCT03759288

Find a site near you

Start Over

Trialspark

Astoria, NY United States
4.14miles
  Connect »

Trialspark

New York, NY United States
7.01miles
  Connect »

Trialspark, Inc.

New York, NY United States
7.88miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.